NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel ...
- Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in ...
A key performance indicator (KPI) is a measurable value that demonstrates how effectively a company, department or individual is achieving key business objectives. KPIs are tracked to evaluate success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback